Monoclonal antibodies to growth hormone (GH) prolong liver GH binding and GH-induced IGF-I/IGFBP-3 synthesis.

Beauloye, Véronique;Muaku, Séverin M.;Lause, Pascale;Portetelle, Daniel;Maiter, Dominique;et.al.
(1999) American journal of physiology — Vol. 277, n° 2 Pt 1, p. E308-E315 (1999)

Files

26116.pdf
  • Restricted Access
  • Adobe PDF
  • 276.54 KB

Details

Authors
  • Beauloye, VéroniqueUCLouvain
    Author
  • Muaku, Séverin M.UCLouvain
    Author
  • Author
  • Portetelle, Daniel
    Author
  • Robert, AnnieUCLouvain
    Author
  • Ketelslegers, Jean-MarieUCLouvain
    Author
  • Author
Show more
Abstract
This time-course study further explored the mechanisms whereby monoclonal antibodies (MAbs) may enhance growth hormone (GH) effects. Hypophysectomized rats were killed 0, 1, 3, 6, 12, 24, and 48 h after a single injection of bovine (b) GH alone or complexed with an anti-bGH MAb. Serum insulin-like growth factor I (IGF-I) concentrations were increased more and for a longer period after MAb-GH complexes (peak at 24 h: 295 +/- 24 ng/ml) than after bGH alone (peak at 12 h: 219 +/- 37 ng/ml; P < 0.01), whereas liver IGF-I mRNA was similar at 12 h in both groups but remained higher at 24 h (by 65%, P < 0.001) and 48 h (by 64%, P < 0.001) in the presence of the MAb. Induction of serum insulin-like growth factor-binding protein (IGFBP)-3 and liver IGFBP-3 mRNA by bGH also was markedly amplified by the MAb (3.6- and 2-fold at 24 h, respectively; P < 0.01). GH receptors (GHR) remained occupied for a longer period after MAb-GH injection (36 +/- 16 and 35 +/- 8% at 6 and 12 h, respectively) compared with bGH alone (0 +/- 28 and -15 +/- 11%), whereas total liver GH-binding sites and GHR mRNA levels were not affected by the MAb. We conclude that MAbs against GH amplify and prolong the serum IGF-I response to GH, which may result from both a prolongation of liver IGF-I synthesis and an enhanced induction of IGFBP-3. These two effects may in turn be the consequences of sustained GH binding to its liver receptors in the presence of MAb.
Affiliations

Citations

Beauloye, V., Muaku, S. M., Lause, P., Portetelle, D., Renaville, R., Robert, A., Ketelslegers, J.-M., & Maiter, D. (1999). Monoclonal antibodies to growth hormone (GH) prolong liver GH binding and GH-induced IGF-I/IGFBP-3 synthesis. American journal of physiology, 277(2 Pt 1), E308-E315. https://doi.org/10.1152/ajpendo.1999.277.2.E308 (Original work published 1999)